Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DOX vs CTSH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DOX
Amdocs Limited

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$7.06B
5Y Perf.+4.6%
CTSH
Cognizant Technology Solutions Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$24.61B
5Y Perf.-2.0%

DOX vs CTSH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DOX logoDOX
CTSH logoCTSH
IndustrySoftware - InfrastructureInformation Technology Services
Market Cap$7.06B$24.61B
Revenue (TTM)$4.58B$21.41B
Net Income (TTM)$572M$2.23B
Gross Margin37.6%32.1%
Operating Margin17.7%15.7%
Forward P/E8.7x9.1x
Total Debt$826M$1.57B
Cash & Equiv.$325M$1.90B

DOX vs CTSHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DOX
CTSH
StockMay 20May 26Return
Amdocs Limited (DOX)100104.6+4.6%
Cognizant Technolog… (CTSH)10098.0-2.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: DOX vs CTSH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DOX leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Cognizant Technology Solutions Corporation is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
DOX
Amdocs Limited
The Income Pick

DOX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.58, yield 3.1%
  • 36.5% 10Y total return vs CTSH's 0.0%
  • Lower volatility, beta 0.58, Low D/E 23.8%, current ratio 1.17x
Best for: income & stability and long-term compounding
CTSH
Cognizant Technology Solutions Corporation
The Growth Play

CTSH is the clearest fit if your priority is growth exposure and valuation efficiency.

  • Rev growth 7.0%, EPS growth 0.9%, 3Y rev CAGR 2.8%
  • PEG 0.75 vs DOX's 1.37
  • 7.0% revenue growth vs DOX's -9.4%
Best for: growth exposure and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthCTSH logoCTSH7.0% revenue growth vs DOX's -9.4%
ValueCTSH logoCTSHPEG 0.75 vs 1.37
Quality / MarginsDOX logoDOX12.5% margin vs CTSH's 10.4%
Stability / SafetyDOX logoDOXBeta 0.58 vs CTSH's 0.75
DividendsDOX logoDOX3.1% yield, 12-year raise streak, vs CTSH's 2.4%
Momentum (1Y)DOX logoDOX-24.7% vs CTSH's -31.7%
Efficiency (ROA)CTSH logoCTSH10.9% ROA vs DOX's 9.0%, ROIC 18.7% vs 15.6%

DOX vs CTSH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DOXAmdocs Limited
FY 2025
Managed services arrangements
66.1%$3.0B
Others
33.9%$1.5B
CTSHCognizant Technology Solutions Corporation
FY 2025
Healthcare Segment
30.1%$6.3B
Financial Services
29.2%$6.2B
Products and Resources
25.0%$5.3B
Communication, Media and Technology
15.6%$3.3B

DOX vs CTSH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDOXLAGGINGCTSH

Income & Cash Flow (Last 12 Months)

DOX leads this category, winning 5 of 6 comparable metrics.

CTSH is the larger business by revenue, generating $21.4B annually — 4.7x DOX's $4.6B. Profitability is closely matched — net margins range from 12.5% (DOX) to 10.4% (CTSH).

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
RevenueTrailing 12 months$4.6B$21.4B
EBITDAEarnings before interest/tax$1.0B$3.9B
Net IncomeAfter-tax profit$572M$2.2B
Free Cash FlowCash after capex$755M$2.5B
Gross MarginGross profit ÷ Revenue+37.6%+32.1%
Operating MarginEBIT ÷ Revenue+17.7%+15.7%
Net MarginNet income ÷ Revenue+12.5%+10.4%
FCF MarginFCF ÷ Revenue+16.5%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year+4.1%+5.8%
EPS Growth (YoY)Latest quarter vs prior year+9.0%+3.7%
DOX leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CTSH leads this category, winning 6 of 7 comparable metrics.

At 11.4x trailing earnings, CTSH trades at a 12% valuation discount to DOX's 12.9x P/E. Adjusting for growth (PEG ratio), CTSH offers better value at 0.94x vs DOX's 2.03x — a lower PEG means you pay less per unit of expected earnings growth.

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
Market CapShares × price$7.1B$24.6B
Enterprise ValueMkt cap + debt − cash$7.6B$24.3B
Trailing P/EPrice ÷ TTM EPS12.90x11.42x
Forward P/EPrice ÷ next-FY EPS est.8.74x9.14x
PEG RatioP/E ÷ EPS growth rate2.03x0.94x
EV / EBITDAEnterprise value multiple7.43x5.95x
Price / SalesMarket cap ÷ Revenue1.56x1.17x
Price / BookPrice ÷ Book value/share2.10x1.67x
Price / FCFMarket cap ÷ FCF10.95x9.48x
CTSH leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

CTSH leads this category, winning 6 of 8 comparable metrics.

DOX delivers a 16.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $15 for CTSH. CTSH carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOX's 0.24x.

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
ROE (TTM)Return on equity+16.5%+14.8%
ROA (TTM)Return on assets+9.0%+10.9%
ROICReturn on invested capital+15.6%+18.7%
ROCEReturn on capital employed+16.8%+21.1%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.24x0.10x
Net DebtTotal debt minus cash$501M-$326M
Cash & Equiv.Liquid assets$325M$1.9B
Total DebtShort + long-term debt$826M$1.6B
Interest CoverageEBIT ÷ Interest expense23.45x107.78x
CTSH leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

DOX leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in DOX five years ago would be worth $9,650 today (with dividends reinvested), compared to $7,708 for CTSH. Over the past 12 months, DOX leads with a -24.7% total return vs CTSH's -31.7%. The 3-year compound annual growth rate (CAGR) favors CTSH at -3.4% vs DOX's -7.7% — a key indicator of consistent wealth creation.

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
YTD ReturnYear-to-date-18.0%-35.7%
1-Year ReturnPast 12 months-24.7%-31.7%
3-Year ReturnCumulative with dividends-21.3%-9.8%
5-Year ReturnCumulative with dividends-3.5%-22.9%
10-Year ReturnCumulative with dividends+36.5%+0.0%
CAGR (3Y)Annualised 3-year return-7.7%-3.4%
DOX leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

DOX leads this category, winning 2 of 2 comparable metrics.

DOX is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than CTSH's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOX currently trades 68.3% from its 52-week high vs CTSH's 59.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
Beta (5Y)Sensitivity to S&P 5000.58x0.75x
52-Week HighHighest price in past year$95.41$87.03
52-Week LowLowest price in past year$62.75$50.81
% of 52W HighCurrent price vs 52-week peak+68.3%+59.7%
RSI (14)Momentum oscillator 0–10041.923.6
Avg Volume (50D)Average daily shares traded980K5.9M
DOX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

DOX leads this category, winning 2 of 2 comparable metrics.

Wall Street rates DOX as "Buy" and CTSH as "Hold". Consensus price targets imply 60.4% upside for CTSH (target: $83) vs 38.2% for DOX (target: $90). For income investors, DOX offers the higher dividend yield at 3.08% vs CTSH's 2.44%.

MetricDOX logoDOXAmdocs LimitedCTSH logoCTSHCognizant Technol…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$90.00$83.33
# AnalystsCovering analysts1151
Dividend YieldAnnual dividend ÷ price+3.1%+2.4%
Dividend StreakConsecutive years of raises129
Dividend / ShareAnnual DPS$2.01$1.27
Buyback YieldShare repurchases ÷ mkt cap+7.8%+5.6%
DOX leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

DOX leads in 4 of 6 categories (Income & Cash Flow, Total Returns). CTSH leads in 2 (Valuation Metrics, Profitability & Efficiency).

Best OverallAmdocs Limited (DOX)Leads 4 of 6 categories
Loading custom metrics...

DOX vs CTSH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is DOX or CTSH a better buy right now?

For growth investors, Cognizant Technology Solutions Corporation (CTSH) is the stronger pick with 7.

0% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DOX or CTSH?

On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.

4x versus Amdocs Limited at 12. 9x. On forward P/E, Amdocs Limited is actually cheaper at 8. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cognizant Technology Solutions Corporation wins at 0. 75x versus Amdocs Limited's 1. 37x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — DOX or CTSH?

Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -3.

5%, compared to -22. 9% for Cognizant Technology Solutions Corporation (CTSH). Over 10 years, the gap is even starker: DOX returned +36. 5% versus CTSH's +0. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DOX or CTSH?

By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.

58β versus Cognizant Technology Solutions Corporation's 0. 75β — meaning CTSH is approximately 31% more volatile than DOX relative to the S&P 500. On balance sheet safety, Cognizant Technology Solutions Corporation (CTSH) carries a lower debt/equity ratio of 10% versus 24% for Amdocs Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — DOX or CTSH?

By revenue growth (latest reported year), Cognizant Technology Solutions Corporation (CTSH) is pulling ahead at 7.

0% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: Amdocs Limited grew EPS 18. 8% year-over-year, compared to 0. 9% for Cognizant Technology Solutions Corporation. Over a 3-year CAGR, CTSH leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DOX or CTSH?

Amdocs Limited (DOX) is the more profitable company, earning 12.

5% net margin versus 10. 6% for Cognizant Technology Solutions Corporation — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOX leads at 18. 2% versus 16. 7% for CTSH. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DOX or CTSH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Cognizant Technology Solutions Corporation (CTSH) is the more undervalued stock at a PEG of 0. 75x versus Amdocs Limited's 1. 37x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Amdocs Limited (DOX) trades at 8. 7x forward P/E versus 9. 1x for Cognizant Technology Solutions Corporation — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTSH: 60. 4% to $83. 33.

08

Which pays a better dividend — DOX or CTSH?

All stocks in this comparison pay dividends.

Amdocs Limited (DOX) offers the highest yield at 3. 1%, versus 2. 4% for Cognizant Technology Solutions Corporation (CTSH).

09

Is DOX or CTSH better for a retirement portfolio?

For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), 3. 1% yield). Both have compounded well over 10 years (DOX: +36. 5%, CTSH: +0. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DOX and CTSH?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DOX

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 1.2%
Run This Screen
Stocks Like

CTSH

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DOX and CTSH on the metrics below

Revenue Growth>
%
(DOX: 4.1% · CTSH: 5.8%)
Net Margin>
%
(DOX: 12.5% · CTSH: 10.4%)
P/E Ratio<
x
(DOX: 12.9x · CTSH: 11.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.